JN
Jakkampudi Naga Sravani
About Jakkampudi Naga Sravani
Data last updated:
Jakkampudi Naga Sravani is a Director at Smo Clinical Research (India) Private Limited (since 2007) and Director at Indya Clinical Research Private Limited (since 2007). The companies operate in Pharma. The 2 current companies with reported revenue have a combined latest revenue of ₹56.9 Lakh; the largest is Smo Clinical Research (India) Private Limited at ₹30.4 Lakh (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Smo Clinical Research (India) Private Limited U73100KA2007PTC042650 | Director | 30 Apr 2007 | 2007 | ₹30.4 Lakh (FY 2025) | Active |
| Indya Clinical Research Private Limited U85110KA2007PTC042648 | Director | 30 Apr 2007 | 2007 | ₹26.5 Lakh (FY 2025) | Active |
Board colleagues of Jakkampudi Naga Sravani
| Name | DIN | Company | Designation |
|---|---|---|---|
| Rakshith Katta Ramanjaneya | 10324486 | Smo Clinical Research (India) Private Limited , Indya Clinical Research Private Limited | Director |
| Ramanjaneya Hanumanthappa Katta | 02980197 | Smo Clinical Research (India) Private Limited , Indya Clinical Research Private Limited | Managing Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Jakkampudi Naga Sravani
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Jakkampudi Naga Sravani
Jakkampudi Naga Sravani currently holds 2 directorships: Smo Clinical Research (India) Private Limited (Director, since 30 Apr 2007, revenue ₹30.4 Lakh (FY 2025)); Indya Clinical Research Private Limited (Director, since 30 Apr 2007, revenue ₹26.5 Lakh (FY 2025)).
Jakkampudi Naga Sravani was first appointed on 30 Apr 2007 as Director at Smo Clinical Research (India) Private Limited.
The 2 current companies of Jakkampudi Naga Sravani that report revenue have a combined latest revenue of ₹56.9 Lakh: Smo Clinical Research (India) Private Limited ₹30.4 Lakh (FY 2025); Indya Clinical Research Private Limited ₹26.5 Lakh (FY 2025).
The current boards of Jakkampudi Naga Sravani's companies include Rakshith Katta Ramanjaneya (Smo Clinical Research (India) Private Limited), Ramanjaneya Hanumanthappa Katta (Smo Clinical Research (India) Private Limited).